Literature DB >> 24468741

Huge myoid hamartoma of the breast treated with reduction mammaplasty: report of a case.

Takaya Makiguchi1, Jun Horiguchi, Rin Nagaoka, Satoshi Yokoo, Hiroto Terashi, Tetsunari Oyama, Izumi Takeyoshi.   

Abstract

Breast hamartoma is an uncommon benign tumor characterized by the variety of component tissues. Adipose tissue, mammary glands, and fibrous tissue in various proportions are the main components and form a well-circumscribed mass. Myoid (muscular) hamartoma is an extremely rare subtype of breast hamartoma, which contains an additional smooth muscle component. Inadequate breast contour and nipple-areola complex malposition and expansion can occur after resection of a large myoid hamartoma. Immediate mammaplasty for the affected breast, using the dermoglandular flap technique, is required to provide symmetry of the bilateral breasts. We report a case of myoid hamartoma that was larger than ever documented before. An acceptable aesthetic result was achieved by resection and application of reduction mammaplasty in a single-stage operation.

Entities:  

Mesh:

Year:  2014        PMID: 24468741     DOI: 10.1007/s00595-014-0833-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  14 in total

1.  Lobular Neoplasia within a Myoid Hamartoma of the Breast.

Authors:  Marie E Mathers; Jyotsna Shrimankar
Journal:  Breast J       Date:  2004 Jan-Feb       Impact factor: 2.431

2.  Oncoplastic surgery in a Japanese patient with breast cancer in the lower inner quadrant area: partial mastectomy using horizontal reduction mammoplasty.

Authors:  Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Tadao Mizoguchi; Sumiya Ishigami; Akihiro Nakajo; Hideo Arima; Shinichi Ueno; Shoji Natsugoe
Journal:  Breast Cancer       Date:  2010-12-25       Impact factor: 4.239

3.  A new technique for reduction mammaplasty.

Authors:  L Ribeiro
Journal:  Plast Reconstr Surg       Date:  1975-03       Impact factor: 4.730

4.  A case of muscular hamartoma of the breast.

Authors:  M Takeuchi; Y Kashiki; C Shibuya; S Yamamoto; F Kitamura; Y Nagao; H Oota; N Yoshimi
Journal:  Breast Cancer       Date:  2001       Impact factor: 4.239

Review 5.  Oncoplastic breast surgery combining partial mastectomy with immediate breast reshaping using a keyhole-shaped skin glandular flap for Paget's disease.

Authors:  Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Akihiro Nakajo; Hideo Arima; Hiroshi Okumura; Takaaki Arigami; Sumiya Ishigami; Shoji Natsugoe
Journal:  Surg Today       Date:  2013-08-08       Impact factor: 2.549

6.  Myoid hamartoma of the breast that proved difficult to diagnose: a case report.

Authors:  Naruhiko Mizuta; Koichi Sakaguchi; Mitsuhiko Mizuta; Aya Imai; Katsuhiko Nakatsukasa; Midori Morita; Mari Soshi; Mariko Goto; Satoru Yasukawa; Eiichi Konishi; Tetsuya Taguchi
Journal:  World J Surg Oncol       Date:  2012-01-16       Impact factor: 2.754

7.  Muscular hamartomas of the breast.

Authors:  J D Davies; R H Riddell
Journal:  J Pathol       Date:  1973-11       Impact factor: 7.996

8.  The identification and treatment of mammary hamartoma.

Authors:  M G Arrigoni; M B Dockerty; E S Judd
Journal:  Surg Gynecol Obstet       Date:  1971-10

9.  Oncoplastic technique combining an adipofascial flap with an extended glandular flap for the breast-conserving reconstruction of small dense breasts.

Authors:  Tomoko Ogawa; Noriko Hanamura; Masako Yamashita; Hiroko Kimura; Minori Ito; Takashi Nakamura; Yumi Kashikura; Yuki Nohara; Aya Noro
Journal:  J Breast Cancer       Date:  2012-12-31       Impact factor: 3.588

10.  Application of reduction mammaplasty in treatment of giant breast tumour.

Authors:  Y Yamamoto; T Sugihara
Journal:  Br J Plast Surg       Date:  1998-03
View more
  1 in total

1.  Genetic Characterization of Myoid Hamartoma of the Breast.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Hege Kilen Andersen; Thomas Dahl Pedersen; Jon Lømo; Marius Lund-Iversen; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.